CCSD code K5810 – Intracardiac electrophysiological study

Key takeaways

CCSD Code K5810 covers the complete diagnostic intracardiac EPS, not just surface ECG monitoring or a standalone pacing test.

Antiarrhythmic drug efficacy testing by programmed stimulation is included within K5810, not a separately billable add-on.

Catheter ablation on the same date uses its own CCSD code. Billing K5810 alone when ablation also took place is the most common coding error.

A valid K5810 claim needs documented baseline intervals (AH, HV, SNRT), the pacing protocols used, and arrhythmia inducibility findings in the EP report.

Pabau, the practice management platform we build, keeps the structured EP report and the insurer claim in the same patient record.

CCSD Code K5810: Definition and clinical scope

CCSD Code K5810 is the code UK private medical insurers use for a diagnostic intracardiac electrophysiological study (EPS). Its descriptor covers characterisation of intracardiac conduction and any testing of antiarrhythmic drug efficacy by programmed stimulation. It is distinct from the codes for catheter ablation, device implantation, and non-invasive cardiac monitoring.

The CCSD schedule comes from the Clinical Coding & Schedule Development Group, which maintains it. It assigns alphanumeric codes to procedures that UK private healthcare providers perform. K5810 sits in chapter 8 (Thorax and intra-thoracic organs), under sub-chapter 8.9, Heart – Cardiology, alongside the catheter ablation codes. Neighbouring codes are easiest to check in our CCSD index for billers.

The K5810 descriptor names two components. The first is characterisation of intracardiac conduction, meaning baseline electrogram recording and interval measurement. The second is testing of antiarrhythmic drug efficacy by programmed stimulation. Both sit under one code, so billing them as two separate codes on the same date is unbundling.

Insurers apply the schedule in their own way. Our guide to Bupa CCSD codes covers Bupa’s current rules for K-series cardiology entries.

What the intracardiac electrophysiological study involves

The team performs the procedure in a cardiac catheterisation laboratory under sterile conditions, typically with fluoroscopic guidance. They gain vascular access, usually via the femoral vein, and then advance multipolar electrode catheters to defined intracardiac positions. These are the high right atrium, the His bundle region, the right ventricular apex, and the coronary sinus for left atrial recording.

Once catheters are positioned, the study proceeds in two phases. The first is baseline conduction characterisation, in which the operator records intracardiac electrograms and measures key intervals. The second is programmed electrical stimulation. The operator paces the heart at defined drive-cycle lengths and introduces progressively premature extrastimuli to assess arrhythmia inducibility.

When the operator tests antiarrhythmic drugs, they give the drug intravenously or orally and repeat the stimulation protocol after a suitable interval. The K5810 code covers both phases within a single billing unit.

Key measurements recorded during K5810

What K5810 includes and excludes

K5810 bundles several components that coders sometimes attempt to bill separately. Understanding the inclusion boundary prevents both under-coding and unbundling errors.

Included within K5810

• Intracardiac catheter placement and electrogram recording
• Measurement of baseline conduction intervals (AH, HV, SNRT)
• Programmed electrical stimulation using any drive-cycle and extrastimulus protocol
• Antiarrhythmic drug administration and re-stimulation testing where performed
• Standard fluoroscopic guidance during catheter positioning
• The formal EP study report documenting all findings

Not included in K5810

• Catheter ablation of an arrhythmia substrate, even if performed immediately after the diagnostic EPS on the same date
• Arrhythmia mapping procedures with dedicated electroanatomical mapping systems
• Implantable loop recorder insertion or device interrogation
• Surface 12-lead or ambulatory ECG monitoring only (no intracardiac access)
• Temporary pacing during a procedure billed under a separate intervention code

Antiarrhythmic drug efficacy testing under K5810

The K5810 descriptor explicitly includes drug testing by programmed stimulation. This means a practice cannot bill K5810 plus an additional code for the pharmacological challenge component. The phrase “any testing of antiarrhythmic drug efficacy” in the official descriptor covers every drug-and-restimulation cycle performed during the same session.

Documentation must record the drug used, dose, route, timing relative to stimulation, and the re-inducibility result after the drug dose.

Clinical indications for K5810

K5810 is correct when the documented clinical purpose is a complete diagnostic intracardiac EPS, regardless of the underlying arrhythmia. The accepted indications in UK private cardiology practice include the following.

• Supraventricular tachycardia (SVT): Including AVNRT, AVRT, and atrial tachycardia where catheter ablation is planned or the mechanism remains unclear after non-invasive testing.
• Ventricular tachycardia (VT): For induction and characterisation of sustained VT, including post-myocardial infarction scar-related VT and idiopathic VT. K5810 is appropriate when the study goal is diagnostic characterisation, even if ablation follows on the same list.
• Wolff-Parkinson-White syndrome (WPW): To characterise the accessory pathway, measure its effective refractory period, and assess pre-excitation risk before ablation.
• Unexplained syncope: Where non-invasive investigation has not identified the cause and the clinical suspicion is arrhythmic. The EPS assesses sinus node function, AV conduction, and arrhythmia inducibility.
• Sinus node dysfunction: When surface ECG findings are inconclusive and invasive SNRT measurement is required to guide pacemaker decisions.

K5810 is the wrong code when no separate diagnostic study was intended. A therapeutic catheter ablation that includes an obligatory mapping phase takes the ablation code instead.

K5810 vs adjacent electrophysiology codes

The CCSD schedule contains several K-series codes that cover related but distinct electrophysiology procedures. Choosing between them requires knowing exactly what was performed. The table below maps the most commonly confused codes.

K5810 vs catheter ablation: Avoiding the most common coding error

The most frequent K5810 coding error occurs when ablation and a diagnostic EPS are performed on the same date. The diagram below shows how the booking and the EP report decide which codes go on the claim.

The two same-day scenarios work like this.

• Diagnostic EPS followed by same-session ablation: The team booked the EP study as a separate diagnostic procedure, and the decision to ablate rested on its findings. Both K5810 and the appropriate ablation code may then be billable. The EP report must clearly document the diagnostic phase separately, including a decision point before ablation commenced.
• Ablation with incidental baseline measurements: The booking and clinical intent were for ablation from the outset. The team recorded baseline conduction intervals as part of the ablation workflow, so you cannot bill K5810 separately. The ablation code encompasses routine preliminary measurements.

The clinical documentation must support whichever position is taken. Insurers reviewing K5810 alongside an ablation code on the same date will expect the EP report to show a distinct diagnostic phase.

Documentation requirements for a K5810 claim

Any UK private insurer will query a K5810 claim that lacks a full EP report. The report must be structured and must document each component that the code descriptor covers. Digital procedure forms that mirror the report structure capture each data point at the point of care. Staff then have no report to rebuild from notes later.

The EP study report needs the following elements to support a K5810 claim.

• Patient and procedural identifiers: Date, operator, institution, indication, vascular access sites.
• Catheter positions documented: Sites of all electrode catheters placed (e.g. high right atrium, His bundle, right ventricular apex, coronary sinus).
• Baseline intracardiac intervals: AH interval (milliseconds), HV interval (milliseconds), and sinus node recovery time (SNRT, corrected SNRT) if assessed.
• Pacing protocols used: Drive-cycle lengths and extrastimulus coupling intervals employed during stimulation. Number of extrastimuli (S2, S3, S4).
• Arrhythmia inducibility findings: Whether any tachyarrhythmia was induced, with its morphology and cycle length. Record the mechanism if determined (e.g. AVNRT with AH jump, accessory pathway-mediated tachycardia).
• Drug testing documentation (if applicable): Drug name, dose, route and timing. Repeat stimulation protocol and re-inducibility result after drug administration.
• Conclusion and clinical decision: Summary of findings with recommendation (e.g. proceed to ablation, commence antiarrhythmic therapy, further investigation).

Pre-authorisation with UK private insurers

Major UK private medical insurers treat K5810 as a procedure requiring pre-authorisation before the patient attends. This is standard for any invasive cardiology procedure. Billing without a valid authorisation reference number is the single most reliably avoidable cause of K5810 claim denial.

Each insurer has its own portal and submission requirements, but the information requested is broadly consistent. Build the authorisation step into the booking workflow, so staff complete it before they list the patient rather than after the procedure.

Pre-authorisation requirements change periodically. Always verify current requirements directly with each insurer’s provider portal before submitting. Record the authorisation reference number in the patient record before listing the procedure.

Benefit levels differ between insurers too. Our breakdown of the Bupa fee schedule shows how one insurer sets its maximums for CCSD entries.

Common reasons K5810 claims are denied

K5810 denial patterns are consistent across UK private insurers. Most stem from incomplete documentation rather than wrong code selection. The causes below account for most denials.

• Missing pre-authorisation: Staff performed the procedure without a valid authorisation reference number, or obtained the authorisation after the procedure date. This is the leading cause of denial and is entirely preventable.
• Incomplete EP report: The submitted report omits required quantitative measurements (AH interval, HV interval) or does not document the pacing protocol used. A narrative summary (“EPS performed, normal conduction”) is insufficient without values.
• Unbundling of drug testing component: Staff add a code for the pharmacological challenge alongside K5810. Insurers applying CCSD bundling rules will reject the additional code because drug testing is explicitly included within K5810.
• Incorrect code selection (diagnostic vs therapeutic confusion): Staff use K5810 for a session that was, in clinical substance, a catheter ablation. The insurer spots the discrepancy in the clinical letter or theatre notes and applies the ablation code, often at a different fee level.
• K5810 billed without a corresponding ablation code when ablation occurred: Where the team performed both a diagnostic EPS and ablation, billing K5810 alone under-represents the procedure. It may also prompt the insurer to query whether the study was genuinely separate.
• Consultant not recognised by the insurer: The operating consultant’s PMI recognition had lapsed, or they never held it for the insurer in question. This is an administrative failure unrelated to the code itself.

How Pabau supports K5810 billing and documentation

Cardiology practices billing K5810 handle two parallel tasks. One is producing a structured EP report that captures every required data point at the point of care. The other is tracking pre-authorisation status before each procedure is listed.

Pabau’s claims management software records the K5810 code against the procedure and sends the claim to UK private insurers through Healthcode. Structured digital forms for the EP report capture the AH interval, HV interval, SNRT, stimulation protocol, and drug testing details. Those values sit in the patient record beside the claim, with no separate document to reconcile later.

Pabau’s compliance tools also support audit readiness by retaining the full procedure documentation alongside the associated claim. When an insurer queries a claim or asks for clinical substantiation, the practice answers from one record instead of searching several systems.

Practices still comparing systems can see how Pabau stacks up in our review of UK medical billing software.

Streamline your cardiology billing workflows

Pabau helps UK private cardiology practices manage CCSD code documentation, pre-authorisation tracking, and clean claim submission from one platform. See how it works for your team.

Book a demo

Conclusion

Get the booking right first, because it settles most K5810 decisions. A diagnostic EPS that the team lists separately from a planned ablation can carry both codes. An ablation the team booked from the outset cannot, whatever baseline measurements were taken.

Then let the EP report do the defending. Quantitative intervals, the pacing protocol, inducibility findings and a clear decision point are what an insurer checks first. A report without them puts the claim at risk even when the code is correct.

The trade-off is a few extra minutes of structured documentation in the lab against weeks spent chasing a queried claim. Book a demo to see how Pabau keeps the EP report, the authorisation and the claim together for your cardiology practice.

Continue your research

Need guidance on CCSD billing across UK insurers? Bupa CCSD procedure codes and fee schedule covers how Bupa applies the CCSD schedule and what billing teams need to know about K-series cardiology codes.

Checking what Bupa pays for a cardiology code? Bupa procedure codes fee schedule explains how Bupa sets benefit maximums for CCSD entries.

Coding another heart procedure from chapter 8? CCSD Code K2310 covers excision of a cardiac tumour and what its claim needs.

Looking to reduce claim denials across your private practice? Claims management software explains how Pabau structures the billing workflow from procedure to clean invoice submission.

Frequently asked questions